Global genomics in
cancer care market is expected to reach USD 9.22 billion by 2022, according to
a new report by Grand View Research, Inc. Increasing prevalence of cancer
coupled with adoption of next generation sequencing for the diagnosis &
treatment is expected to fuel the market with future growth opportunities.
Increasing incidences of cancer triggers the demand for cost effective and
accurate diagnostics in coming years.
In addition,
increasing demand for personalized medicines in molecular characterization of
cancer to identify therapeutic targets is the factor attributing towards the
market growth. Similarly, factors such as cost reduction in genome sequencing,
growing healthcare expenditure levels and development of effective diagnostics
& therapeutic procedures for cancer are responsible for the potential
growth of genomics in cancer care.
Browse
Detail Report With TOC @ http://www.hexareports.com/report/genomics-in-cancer-care-market/details
Further key
findings from the study suggest:
Instrument segment dominated the overall market in terms of revenue share
as of 2014 and accounted for 33.4% of market owing to high cost associated with
it. Whereas, consumables are most widely used product segment in genome testing
as they are indispensible component and frequently required to perform the
test.
Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
Drug discovery and development segment is expected to show lucrative CAGR of 17.6% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products.
Request
A Sample copy of This Report @ http://www.hexareports.com/sample/98212
Table
Of Content
Chapter 1.
Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumptions
1.3. List of data sources
1.1. Research methodology
1.2. Research scope & assumptions
1.3. List of data sources
Chapter 2.
Executive Summary
2.1. Genomics in cancer care- Industry Snapshot And Key Buying Criteria, 2012-2022
2.1. Genomics in cancer care- Industry Snapshot And Key Buying Criteria, 2012-2022
Chapter 3.
Genomics In Cancer Care Industry Outlook
3.1. Genomics in cancer care market segmentation
3.2. Genomics in cancer care market size and growth prospects
3.3. Genomics in cancer care market dynamics
3.4. Key opportunities prioritized
3.5. Industry Analysis - Porter's
3.1. Genomics in cancer care market segmentation
3.2. Genomics in cancer care market size and growth prospects
3.3. Genomics in cancer care market dynamics
3.4. Key opportunities prioritized
3.5. Industry Analysis - Porter's
Chapter 4.
Genomics In Cancer Care Product Outlook
4.1. Genomics in cancer care market share by product, 2014 & 2022
4.2. Instruments
4.3. Consumables & reagents
4.4. Services
4.1. Genomics in cancer care market share by product, 2014 & 2022
4.2. Instruments
4.3. Consumables & reagents
4.4. Services
Contact
Information:
Ryan
Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone
Number
1-800-489-3075
Email
Us: sales@hexareports.com
Our
Website: http://www.hexareports.com/
No comments:
Post a Comment